A Case of Acute Opioid Withdrawal after Liposuction Surgery in a Patient on Extended-release Buprenorphine.

Author: BobbRaymond, MalayalaSrikrishna V, PapudesiBhavani Nagendra, PotluriDeepika

Paper Details 
Original Abstract of the Article :
BACKGROUND: The US Food and Drug Administration approved the once-monthly injectable extended-release buprenorphine product to treat moderate-to-severe opioid use disorders. The patient in our case report had a liposuction procedure and immediately started having opioid withdrawal symptoms after the...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/37788623

データ提供:米国国立医学図書館(NLM)

A Case of Acute Opioid Withdrawal after Liposuction Surgery in a Patient on Extended-release Buprenorphine

This case report delves into a unique and unexpected complication experienced by a patient receiving extended-release buprenorphine for opioid use disorder. Imagine a desert traveler carrying a precious water source – this is how buprenorphine works, providing a sustained release of medication. The authors describe a situation where the patient unexpectedly experienced acute opioid withdrawal symptoms following liposuction surgery, highlighting the potential for unforeseen complications related to this treatment modality.

A Hidden Oasis

The case report reveals a hidden oasis of potential complications associated with extended-release buprenorphine. Like a desert landscape with unexpected hidden dangers, this medication can present unexpected challenges. The authors' findings suggest that liposuction surgery may disrupt the buprenorphine depot, leading to a sudden drop in medication levels and subsequent withdrawal symptoms. This case emphasizes the need for careful consideration and communication between patients, surgeons, and addiction treatment providers.

A Valuable Lesson

This case report serves as a valuable lesson for healthcare providers, underscoring the importance of comprehensive patient assessment and careful consideration of medication interactions. It's a reminder that even in the seemingly familiar landscape of opioid use disorder treatment, unexpected challenges can arise. The authors' findings highlight the need for proactive communication and collaboration between healthcare providers to ensure patient safety and optimal outcomes.

Dr. Camel's Conclusion

This case report highlights the potential for unforeseen complications associated with extended-release buprenorphine, reminding us that even in the seemingly familiar terrain of opioid use disorder treatment, unexpected challenges can arise. It's a valuable lesson for healthcare providers, emphasizing the importance of careful patient assessment, comprehensive communication, and collaborative care to ensure patient safety and optimize outcomes.
Date :
  1. Date Completed 2023-11-08
  2. Date Revised 2023-11-09
Further Info :

Pubmed ID

37788623

DOI: Digital Object Identifier

01271255-202309000-00026

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.